Obesity and thrombosis

被引:239
作者
Darvall, K. A. L.
Sam, R. C.
Silverman, S. H.
Bradbury, A. W.
Adam, D. J.
机构
[1] City Hosp, Dept Vasc Surg, Birmingham, W Midlands, England
[2] Univ Birmingham, Heartlands Hosp, Dept Vasc Surg, Birmingham B15 2TT, W Midlands, England
关键词
obesity; thrombosis; leptin; adiponectin; venous thromboembolism; metabolic syndrome;
D O I
10.1016/j.ejvs.2006.10.006
中图分类号
R61 [外科手术学];
学科分类号
摘要
Objectives. To describe the pathophysiological mechanisms by which obesity increases the propensity to thrombosis, the leading cause of death in the Western World, with particular emphasis on the role of inflammation, oxidative stress, dyslipidaemia, insulin resistance and the coagulation cascade. Design. Review article. Materials and methods. Medline (1966-2005) and Cochrane library review of literature examining the relationship between obesity and thrombosis. Search terms included obesity, overweight, body mass index, thrombosis, cardiovascular disease, venous thromboembolism, peripheral arterial disease, and coronary heart disease. Results. Obesity is an important and growing public health issue that is estimated to affect more than half of the UK adult population. Obesity, in particular central (visceral) obesity, is associated with significant, and largely preventable, morbidity and mortality including an increased incidence and prevalence of arterial and venous thrombotic events. The various mechanisms by which obesity may cause thrombosis include: the actions of so-called adipocytokines from adipose tissue, e.g. leptin and adiponectin; increased activity of the coagulation cascade and decreased activity of the fibrinolytic cascade; increased inflammation; increased oxidative stress and endothelial dysfunction; and disturbances of lipids and glucose tolerance in association with the metabolic syndrome. Conclusions. Obesity appears to be associated with thrombosis via several mechanisms. These pro-thrombotic factors are all improved by weight loss.
引用
收藏
页码:223 / 233
页数:11
相关论文
共 97 条
[21]   Report of the National Heart, Lung, and Blood Institute-National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease [J].
Eckel, RH ;
Barouch, WW ;
Ershow, AG .
CIRCULATION, 2002, 105 (24) :2923-2928
[22]   Association between adiponectin and mediators of inflammation in obese women [J].
Engeli, S ;
Feldpausch, M ;
Gorzelniak, K ;
Hartwig, F ;
Heintze, U ;
Janke, J ;
Möhlig, M ;
Pfeiffer, AFH ;
Luft, FC ;
Sharma, AM .
DIABETES, 2003, 52 (04) :942-947
[23]   Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women - A randomized trial [J].
Esposito, K ;
Pontillo, A ;
Di Palo, C ;
Giugliano, G ;
Masella, M ;
Marfella, R ;
Giugliano, D .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 289 (14) :1799-1804
[24]   Diabetes, lipids, and adipocyte secretagogues [J].
Faraj, M ;
Lu, HL ;
Cianflone, K .
BIOCHEMISTRY AND CELL BIOLOGY, 2004, 82 (01) :170-190
[25]  
Folsom A R, 1992, Ann Epidemiol, V2, P481
[26]   Prospective study of hemostatic factors and incidence of coronary heart disease - The Atherosclerosis Risk in Communities (ARIC) Study [J].
Folsom, AR ;
Wu, KK ;
Rosamond, WD ;
Sharrett, AR ;
Chambless, LE .
CIRCULATION, 1997, 96 (04) :1102-1108
[27]   Association of C-reactive protein with markers of prevalent atherosclerotic disease [J].
Folsom, AR ;
Pankow, JS ;
Tracy, RP ;
Arnett, DK ;
Peacock, JM ;
Hong, YL ;
Djoussé, L ;
Eckfeldt, JH .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 88 (02) :112-117
[28]   Prevalence of the metabolic syndrome among US adults - Findings from the Third National Health and Nutrition Examination Survey [J].
Ford, ES ;
Giles, WH ;
Dietz, WH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (03) :356-359
[29]   DIRECT EFFECTS OF GEMFIBROZIL ON THE FIBRINOLYTIC SYSTEM - DIMINUTION OF SYNTHESIS OF PLASMINOGEN-ACTIVATOR INHIBITOR TYPE-1 [J].
FUJII, S ;
SOBEL, BE .
CIRCULATION, 1992, 85 (05) :1888-1893
[30]   Increased oxidative stress in obesity and its impact on metabolic syndrome [J].
Furukawa, S ;
Fujita, T ;
Shimabukuro, M ;
Iwaki, M ;
Yamada, Y ;
Nakajima, Y ;
Nakayama, O ;
Makishima, M ;
Matsuda, M ;
Shimomura, I .
JOURNAL OF CLINICAL INVESTIGATION, 2004, 114 (12) :1752-1761